Advertisement
Home Tags Chemotherapy

Tag: Chemotherapy

For breast cancer survivors

Anthracyclines More Neurotoxic Than Other Breast CA Regimens

More negative effects on specific cognitive domains, network connections for breast cancer survivors
For women with early-stage breast cancer

Impact of Recurrence Score Assay Varies With Patient Age

For women with early-stage breast cancer, testing lowers chemo use, costs among women <55 years
For patients receiving chemotherapy

ASCO Updates Guidelines for Antiemetics During Chemo

Oral combination of netupitant and palonosetron beneficial for prevention of nausea and vomiting
Lower-level radiation and chemotherapy may be as effective as standard doses for some patients with human papillomavirus-related oropharyngeal squamous cell carcinoma

ASTRO: Less Treatment Effective in HPV-Related Oropharynx CA

Lower doses of chemotherapy, radiation may also reduce unwanted side effects
Chemoradiotherapy is associated with survival benefit over chemotherapy alone for elderly patients with limited-stage small-cell lung cancer

CRT May Be Preferred Strategy for Elderly With Lung Cancer

Increased survival for chemoradiotherapy versus chemotherapy in limited-stage, small-cell lung cancer
As many as half of postsurgical infections and more than a quarter of infections after chemotherapy are caused by organisms already resistant to standard antibiotics

Rising Threat of Antibiotic Resistance in Surgery, Chemo

10 percent rise in antibiotic resistance would lead to 2,100 more deaths, 40,000 more infections yearly
A 21-gene risk of recurrence score can identify patients with breast cancer who may be spared chemotherapy

Prospective Validation of 21-Gene Risk of Recurrence Score

Score identifies breast cancer patients with low risk of recurrence who may be spared adjuvant chemo
Radiation and chemotherapy can cause structural changes in the healthy brain tissue of patients with glioblastoma brain tumors

Chemoradiation for Glioblastoma Takes Toll on Brain

Structural changes include reduced gray matter volume and ventricular enlargement
For patients with unresectable hepatocellular carcinoma

Drug-Eluting Chemoembolization No Better for Hepatocellular CA

No improved survival versus conventional chemoembolization, which has better response rate
Varubi (rolapitant) has been approved by the U.S. Food and Drug Administration to prevent delayed phase chemotherapy-induced nausea and vomiting.

FDA Approves Varubi for Chemo-Induced Nausea, Vomiting

For prevention of the delayed phase of nausea, vomiting caused by chemotherapy